National Stock Number
6505-01-330-8946
National Stock Number (NSN) 6505-01-330-8946, or NIIN 013308946, (dopamine hydrochloride and dextrose injection,usp) was assigned June 11, 1996 in the Federal Logistics Information System (FLIS). NIIN 013308946 was cancelled on June 2, 2015, with a cancelled status of "Item is Cancelled WITHOUT Replacement." There is no known replacement specified for this stock number. This NSN does not replace any other NSNs.
There are 2 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 01, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. The Government physically does not have in its possession sufficient, accurate, or legible data to purchase this part from other than current source(s). (NOTE: This code is applicable only to parts under immediate buy requirements and only as long as the deficiency is under review for resolution and appropriate recoding.) Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 41748. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505013308946 does not contain precious metals.
This information was last updated on Aug 01, 2025.